Better molecules. Faster.
molab.ai provides a step-change in drug and compound discovery through in silico property predictions with unprecedented performance
Market-leading property predictions
Our next-level property predictions (esp. ADMET) substantially accelerate and streamline drug and compound discovery.
Unparalleled robustness to data scarcity
We unlock new AI use cases, through unprecedented performance in data-scarce settings, including in vivo predictions.
Fully interpretable results
We empower scientists to iterate faster by uncovering molecular root causes for the characteristics under investigation.
Vast array of applications
Our integrated solution benefits a comprehensive range of applications across drug discovery and chemistry, such as in vivo ADME, toxicity, physiochemical properties and even scents and flavors.
We are a purpose-driven AI company that combines scientific excellence, impact orientation and entrepreneurial drive. We leverage our unique technology and hands-on approach to our help our clients unlock substantial value, fast.
for the benefit of
patients, people and the planet.